Cancer Research

25 years of integration, innovation, and ideals

2018 marked 25 years since the University of Pennsylvania Health System (UPHS) was first established—a milestone that would undoubtedly make the institution’s founder, Benjamin Franklin, proud.

Penn Today Staff

Energizing the immune system to eat cancer

An Abramson Cancer Center study identifies a method of priming macrophages to boost an anti-tumor response wherein macrophages attack and eat cancer cells.

Penn Today Staff

Hindering melanoma metastasis with an FDA-approved drug

A drug approved by the FDA 65 years ago for blood pressure control may aid in preventing cancer from spreading to distant organs. New research led by Serge Fuchs revealed that this drug disrupted formation of a fertile environment for metastasis by protecting healthy cells from harmful vesicles released by tumors.

Katherine Unger Baillie

CAR T cell therapy leads to lasting remissions

In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor CAR T cell therapy Kymriah® led to long-lasting remissions in patients with non-Hodgkins lymphoma.

Penn Today Staff

Media Contact


In the News

HealthDay News

For Breast Cancer Patients, Less Time on Hormonal Meds?

Susan Domchek of the Perelman School of Medicine and the Abramson Cancer Center comments on hormonal therapy.



Acupuncture in Cancer Study Reignites Debate About Controversial Technique

Rollin Gallagher of the Perelman School of Medicine comments on a clinical trial that focused on whether acupuncture can relieve pain in cancer patients.